During the past decade, Clinica di oncoematologia pediatrica conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinica di oncoematologia pediatrica" #1 sponsor was "European Society for Blood and Marrow Transplantation" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Associazione Italiana Ematologia Oncologia Pediatrica" with 1 trials sponsored, "Jazz Pharmaceuticals" with 1 trials sponsored and "St. Anna Kinderkrebsforschung" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica di oncoematologia pediatrica" #1 collaborator was "European Society for Blood and Marrow Transplantation" with 2 trials as a collaborator, "ALL SCTped Forum" with 1 trials as a collaborator, "ALL-BFM Study Group" with 1 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator and "Australian & New Zealand Children's Haematology/Oncology Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Clinica di oncoematologia pediatrica" are "Hepatic Veno-Occlusive Disease" (2 trials), "Acute Lymphoblastic Leukaemia" (1 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Acute Promyelocytic Leukemia" (1 trials) and "Blood Cancer" (1 trials). Many other conditions were trialed in "Clinica di oncoematologia pediatrica" in a lesser frequency.

Most popular intervention types in "Clinica di oncoematologia pediatrica" are "Drug" (6 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "ATG Thymoglobulin" (1 trials), "All-trans retinoic acid" (1 trials), "Arsenic Trioxide" (1 trials), "Atezolizumab" (1 trials) and "Busulfan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica di oncoematologia pediatrica" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Clinica di oncoematologia pediatrica". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Clinica di oncoematologia pediatrica, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica di oncoematologia pediatrica, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".